Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in various connective tissues, synovial fluid, and ocular tissues. It acts as a lubricant and shock absorber. Exogenous HA is available in various formulations and molecular weights for different clinical applications.
## Primary Indications
* **Osteoarthritis:** Intra-articular injection for pain relief in knee osteoarthritis.
* **Ophthalmology:** Ophthalmic solutions for dry eye relief and viscoelastic solutions used during ophthalmic surgery.
* **Dermatology:** Topical preparations for skin hydration and wound healing.
* **Dermal Fillers:** Injectable formulations for cosmetic augmentation.
## Adult Dosing
* **Osteoarthritis (Knee):**
* **Monovisc:** 2 mL intra-articular injection once.
* **Synvisc/Synvisc-One:** Synvisc: 16 mg (2 mL) intra-articular injection once weekly for 3 weeks. Synvisc-One: 48 mg (6 mL) intra-articular injection once.
* **Euflexxa:** 2 mL intra-articular injection once weekly for 3 weeks.
* **Other formulations:** Dosing varies by product; typically 2-6 mL intra-articular injection weekly for 3-5 weeks, or a single injection of higher molecular weight HA. Consult specific product labeling.
* **Ophthalmology (Dry Eye):**
* **Various artificial tear formulations:** Typically 1-2 drops instilled into the conjunctival sac as needed, up to 4-6 times daily.
* **Ophthalmology (Viscoelastic):** Used intraoperatively by ophthalmologists; dosing is procedure-dependent.
* **Dermatology (Topical):** Follow product-specific instructions for application.
## Pediatric Dosing
Dosing in pediatric patients is not well-established for most indications and is generally not recommended outside of specific clinical trials or expert guidance. Intra-articular HA for osteoarthritis is not indicated in pediatric patients.
## Dose Adjustments
No specific dose adjustments are generally required for renal or hepatic impairment.
## Contraindications
* Known hypersensitivity to hyaluronic acid or any component of the formulation.
* Infection in or around the injection site for intra-articular preparations.
* Severe skin infections or inflammatory skin conditions at the injection site for intra-articular preparations.
## Adverse Effects
* **Intra-articular:** Pain, swelling, stiffness, warmth, redness at the injection site. Transient joint effusion.
* **Ophthalmic:** Temporary blurred vision, stinging, eye irritation, conjunctivitis.
* **Topical/Dermal:** Localized irritation, redness, itching.
## Key Drug Interactions
* **Intra-articular:** Concurrent use of other intra-articular injections (e.g., corticosteroids) may increase the risk of local reactions; generally, separate administration times.
* No significant systemic drug interactions are expected.
## Monitoring
* **Intra-articular:** Monitor for signs of infection or severe inflammatory reactions at the injection site. Assess pain relief and functional improvement.
* **Ophthalmic:** Assess symptom relief from dry eye. Monitor for ocular irritation or adverse reactions.
## Clinical Pearls
* Intra-articular HA for osteoarthritis is a symptomatic treatment and does not alter disease progression.
* Effectiveness and duration of relief can vary significantly between individuals and formulations.
* For ophthalmic use, preservative-free formulations are preferred for frequent use to minimize ocular surface toxicity.
* Ensure proper aseptic technique for all intra-articular injections.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant guidelines for complete details, including warnings, precautions, and potential adverse reactions, as drug information can change.*
